Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aprea Therapeutics, Inc.

1.65
-0.0400-2.37%
Post-market: 1.64-0.0100-0.61%18:23 EDT
Volume:39.10K
Turnover:65.47K
Market Cap:9.13M
PE:-0.70
High:1.72
Open:1.71
Low:1.64
Close:1.69
Loading ...
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2021

Major Issues Report

8-K - Current report
Dec 28, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Jun 30, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2020

Major Issues Report

8-K - Current report